Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 3/20 | 0.47 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5048196 | 0.81 | GDA (0.62) | XDHGDA | |
| SCHEMBL9806979 | 0.74 | XDH (0.71) | XDHGDA | |
| SCHEMBL766669 | 0.74 | XDH (0.66) | XDHGDA | |
| SCHEMBL17274775 | 0.72 | XDH (0.76) | XDHGDA | |
| SCHEMBL5091266 | 0.72 | PDPK1 (0.40) | XDHGDA | |
| SCHEMBL8343189 | 0.72 | PDE4A (0.35) | — | |
| SCHEMBL8196752 | 0.71 | XDH (0.76) | XDHGDA | |
| SCHEMBL9960821 | 0.71 | XDH (0.69) | XDHGDA | |
| SCHEMBL5935074 | 0.71 | XDH (0.78) | XDHGDA | |
| SCHEMBL16197989 | 0.70 | XDH (0.77) | XDHGDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1189941-B1 | NEUROMEDIN B AND SOMATOSTATIN RECEPTOR AGONISTS | IPSEN PHARMA (FR) | 2013-01-09 | — | — | EP | disclosed |
| US-20080132453-A1 | Neuromedin B and somatostatin receptor agonists | IPSEN PHARMA S.A.S. (FR) | 2008-06-05 | — | — | US | disclosed |
| US-6903074-B1 | Neuromedin b and somatostatin receptor agonists | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S. (FR) | 2005-06-07 | — | — | US | disclosed |
| EP-1189941-A1 | NEUROMEDIN B AND SOMATOSTATIN RECEPTOR AGONISTS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 2002-03-27 | — | — | EP | disclosed |
| WO-2000075186-A1 | NEUROMEDIN B AND SOMATOSTATIN RECEPTOR AGONISTS | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES SAS (FR) | 2000-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132453-A1 | Neuromedin B and somatostatin receptor agonists | NMBR, NMUR1, NMUR2 | XDH 3429/4885GDA 3187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.